FAUSTINI, Gaia
 Distribuzione geografica
Continente #
NA - Nord America 1.659
EU - Europa 1.511
AS - Asia 797
SA - Sud America 92
AF - Africa 12
OC - Oceania 4
Totale 4.075
Nazione #
US - Stati Uniti d'America 1.643
PL - Polonia 661
CN - Cina 257
IT - Italia 251
SG - Singapore 243
UA - Ucraina 159
DE - Germania 128
HK - Hong Kong 121
BR - Brasile 81
FI - Finlandia 81
FR - Francia 42
GB - Regno Unito 42
RU - Federazione Russa 42
TR - Turchia 42
IE - Irlanda 40
VN - Vietnam 37
IN - India 24
KR - Corea 18
CZ - Repubblica Ceca 16
ID - Indonesia 16
SE - Svezia 14
CA - Canada 12
NL - Olanda 10
BD - Bangladesh 8
BE - Belgio 8
EG - Egitto 5
IL - Israele 5
IQ - Iraq 5
AT - Austria 4
IR - Iran 4
AR - Argentina 3
AU - Australia 3
CH - Svizzera 3
MX - Messico 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BO - Bolivia 2
BY - Bielorussia 2
EE - Estonia 2
GR - Grecia 2
JO - Giordania 2
JP - Giappone 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
ZA - Sudafrica 2
AO - Angola 1
AZ - Azerbaigian 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
HU - Ungheria 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 4.075
Città #
Warsaw 660
Fairfield 201
Singapore 168
Jacksonville 128
Chandler 120
Hong Kong 120
Ashburn 117
Woodbridge 101
Brescia 93
Cambridge 86
Beijing 83
Seattle 83
Dearborn 77
Houston 73
Princeton 72
Wilmington 68
Helsinki 62
Ann Arbor 61
New York 47
Dublin 40
Dong Ket 36
Istanbul 35
Nanjing 33
Milan 27
Munich 25
Boardman 18
Moscow 18
Los Angeles 17
Des Moines 16
Jakarta 16
Jinan 16
Shanghai 16
Pune 13
San Diego 13
San Giuliano Milanese 13
Shenyang 13
The Dalles 12
Hebei 11
Brno 10
Lappeenranta 9
Nuremberg 9
Changsha 8
San Francisco 8
São Paulo 8
Toronto 8
Turku 8
Brussels 7
Cattolica 7
Rome 7
San Donà Di Piave 7
Tianjin 7
Lanzhou 6
Nanchang 6
Pavia 6
Romola 6
Taizhou 6
Cairo 5
Hangzhou 5
Jiaxing 5
Kunming 5
London 5
Oxford 5
San Cesareo 5
Hefei 4
Napoli 4
Ningbo 4
Olomouc 4
Providence 4
Rio de Janeiro 4
Salò 4
Zhengzhou 4
Ardabil 3
Augusta 3
Bologna 3
Cagliari 3
Fulda 3
Guangzhou 3
Haikou 3
Kafr Manda 3
Kilburn 3
Leawood 3
New Delhi 3
Norwalk 3
Paris 3
Porto Alegre 3
Santa Clara 3
Sulaymaniyah 3
Taiyuan 3
Ulsan 3
Vienna 3
Zurich 3
Amman 2
Ankara 2
Boston 2
Canberra 2
Chengdu 2
Chicago 2
Conselheiro Lafaiete 2
Curitiba 2
Dhaka 2
Totale 3.086
Nome #
Anionic liposomes for siRNA delivery to primary neuronal cells: evaluation of Alpha synuclein knockdown efficacy 278
Dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of Parkinson’s disease: An in situ proximity ligation assay study 265
The Contribution of -Synuclein Spreading to Parkinson’s Disease Synaptopathy 236
Mitochondria and alpha-synuclein: Friends or foes in the pathogenesis of Parkinson's disease? 187
Living in promiscuity: The multiple partners of alpha-synuclein at the synapse in physiology and pathology 186
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 169
Alpha-Synuclein Preserves Mitochondrial Fusion and Function in Neuronal Cells 165
NF-κB/c-Rel deficiency causes Parkinson's disease-like prodromal symptoms and progressive pathology in mice 154
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate 143
Mitochondrial Dysregulation and Impaired Autophagy in iPSC-Derived Dopaminergic Neurons of Multiple System Atrophy 132
Depletion of Progranulin Reduces GluN2B-Containing NMDA Receptor Density, Tau Phosphorylation, and Dendritic Arborization in Mouse Primary Cortical Neurons 130
Synapsin III alterations in Parkinson's disease 124
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 112
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease 104
AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons of Synapsin III knockout mice reveals novel molecular features involved in Parkinson's disease pathology. 91
Involvement of Synapsin III in the onset of Alpha-synuclein pathology in Parkinson’s Disease 89
Synapsin III and Alpha-Synuclein cooperation in the onset of synaptic pathology in Parkinson’s Disease 89
Parkinson's disease: from synaptic loss to connectome dysfunction 88
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of Parkinson’s disease and dementia with Lewy bodies, 87
Study of alpha-synuclein fibrillation: State of the art and expectations 87
Synapsin III knock-out reduces AAV-alpha-synuclein overexpression-related neuropathology in the nigrostriatal system 85
Design and Synthesis of Fluorescent Methylphenidate Analogues for a FRET-Based Assay of Synapsin III Binding 83
Exploring LRRK2-dependent clearance of α-synuclein pffs in glial cells via clusterin 79
The good and bad of therapeutic strategies that directly target α-synuclein 79
Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s disease 76
Alpha-Synuclein in the Regulation of Brain Endothelial and Perivascular Cells: Gaps and Future Perspectives 74
. Alpha-synuclein is a crucial mediator of mitochondrial fusion and functions 72
Alpha-synuclein absence affected mitochondrial fusion and functions 67
Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytes 66
Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and synaptic protein’s redistribution 63
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease 61
An updated reappraisal of synapsins: structure, function and role in neurological and psychiatric disorders 59
Alpha-Synuclein is Involved in DYT1 Dystonia Striatal Synaptic Dysfunction 58
Validation of synapsin III as a therapeutic target for Parkinson’s disease in the AAV-mediated alpha-synuclein mouse model 44
Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype 43
Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson’s Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice 42
The association between α-synuclein and α-tubulin in brain synapses 42
Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy? 37
Synapsin III Regulates Dopaminergic Neuron Development in Vertebrates 35
Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson's Disease 32
DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson’s disease 32
Early α-synuclein/synapsin III co-accumulation, nigrostriatal dopaminergic synaptopathy and denervation in the MPTPp mouse model of Parkinson's Disease 28
Totale 4.173
Categoria #
all - tutte 20.883
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.883


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202048 0 0 0 0 0 0 0 0 0 0 0 48
2020/2021716 39 59 36 74 58 59 26 76 68 92 65 64
2021/2022339 29 43 23 12 4 28 13 28 19 25 41 74
2022/2023376 50 1 10 30 35 93 3 38 64 10 18 24
2023/2024422 35 8 39 37 20 80 17 16 73 10 14 73
2024/2025824 5 13 19 107 98 64 96 52 92 45 149 84
Totale 4.173